Tait D, Diacon A, Borges AH, van Brakel E, et al. Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial. J Infect Dis 2024 Apr 1:jiae170. doi: 10.1093.
PMID: 38557639